# Amide Technologies: Peptide sourcing shouldn't stand in the way of discovery\.

> Advanced AFPS technology delivers fast, reliable synthesis of complex peptides—enabling novel structures and more effective clinical programs\.

Generated by Yoast SEO v28.6, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Branched Peptides and Mini Proteins](https://www.amidetech.com/branched-peptides-and-mini-proteins/)
- [Linear Peptide Synthesis](https://www.amidetech.com/linear-peptide-synthesis/)
- [Home](https://www.amidetech.com/)
- [Blog Articles](https://www.amidetech.com/blog-articles/)
- [Technology](https://www.amidetech.com/technology/)

## Posts
- [Outsourcing Peptide Synthesis: What Drug Discovery Teams Should Know Before Choosing a CRO](https://www.amidetech.com/blog/outsourcing-peptide-synthesis-what-drug-discovery-teams-should-know-before-choosing-a-cro/)
- [Branched Peptides in Vaccine Development: A New Frontier](https://www.amidetech.com/blog/branched-peptides-in-vaccine-development-a-new-frontier/)
- [What Are Branched Peptides, and Why Do They Matter in Drug Discovery?](https://www.amidetech.com/blog/what-are-branched-peptides-and-why-do-they-matter-in-drug-discovery/)
- [The Synthesis Gap: Why the Distance Between Peptide Design and Peptide Manufacturing Is the Biggest Bottleneck in Drug Discovery](https://www.amidetech.com/blog/the-synthesis-gap-why-the-distance-between-peptide-design-and-peptide-manufacturing-is-the-biggest-bottleneck-in-drug-discovery/)
- [Branched Peptides vs\. Mini Proteins: Choosing the Right Modality for Your Target](https://www.amidetech.com/blog/branched-peptides-vs-mini-proteins-choosing-the-right-modality-for-your-target/)

## Global Sections
- [CTA \- Careers](https://www.amidetech.com/blog/global_sections/cta-careers/)
- [CTA \- Is Your Drug Discovery Engine Designing Peptides You Can't Make?](https://www.amidetech.com/blog/global_sections/cta-is-your-drug-discovery-ai-designing-peptides-you-cant-make/)
- [CTA \- Interested In Learning More?](https://www.amidetech.com/blog/global_sections/cta-interested-in-learning-more/)
- [CTA \- Interested In Learning More? \- White Background](https://www.amidetech.com/blog/global_sections/cta-interested-in-learning-more-white-background/)

## Team
- [Nessan Bermingham](https://www.amidetech.com/team/nessan-bermingham/)
- [Jeremy Wertheimer, PhD](https://www.amidetech.com/team/jeremy-wertheimer-phd/)
- [Brad Pentelute, PhD](https://www.amidetech.com/team/brad-pentelute-phd/)
- [Mark Simon, PhD](https://www.amidetech.com/team/mark-simon-phd/)
- [Phil Dixon](https://www.amidetech.com/team/phil-dixon/)

## Press
- [Amide Technologies Announces Complex Peptide Manufacturing Platform, Raises $16\.5M to Expedite Frontier Drug Discovery](https://www.amidetech.com/press/manufacturing_platform_announcement/)
- [Amide Technologies Appoints Co\-Founder and MIT Chemistry Professor as CEO](https://www.amidetech.com/press/amide-technologies-appoints-cofounder-as-ceo/)
- [Endpoints News:  MIT spinout aims to improve manufacturing of peptides](https://www.amidetech.com/press/endpoints-news-mit-spinout-aims-to-improve-manufacturing-of-peptides/)
- [Synthesis of Proteins By Automated Flow Chemistry](https://www.amidetech.com/press/synthesis-of-proteins-by-automated-flow-chemistry/)
- [Parallel Automated Flow Synthesis of Covalent Protein Complexes That Can Inhibit MYC\-Driven Transcription](https://www.amidetech.com/press/parallel-automated-flow-synthesis-of-covalent-protein-complexes-that-can-inhibit-myc-driven-transcription/)

## Roles
- [Advisors/Investors](https://www.amidetech.com/blog/team_member_role/advisors-investors/)
- [Leadership](https://www.amidetech.com/blog/team_member_role/leadership/)
- [Team](https://www.amidetech.com/blog/team_member_role/team/)
- [Board](https://www.amidetech.com/blog/team_member_role/board/)

## Optional
- [Sitemap index](https://www.amidetech.com/sitemap_index.xml)